Mohamed Sayed Abdelmoneim

Dr. Mohamed completed his BSc in Pharmaceutical Sciences from Cairo University in 2001. In 2005, he joined HGH and experienced several scopes of pharmacy practice. He participated in several clinical protocols, drug use evaluations and has several research contributions including RCTs in Orphan Medications, Emergency Medicines, and Neurology. He obtained his MSc in clinical pharmacy in 2014 from Queen’s University Belfast and currently working as a Clinical Pharmacy Specialist in Neurology - Neurosciences Institute. Dr. Mohamed is interested mainly in Anti-thrombotic, Anti-seizure and Monoclonal antibody medications.